Evidence map›Paper›PMID 32369665›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2020

The GRIA3 c.2477G > A Variant Causes an Exaggerated Startle Reflex, Chorea, and Multifocal Myoclonus.

Juliette Piard, Matthieu Béreau, Wenshu XiangWei, Thomas Wirth, Daniel Amsallem, Lauren Buisson, Philippe Richard, Nana Liu, Yuchen Xu, Scott J Myers and 6 more

Open access · greenAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Frontiers in cellular neuroscience · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Sleep Disorders in Patients with Choreic Syndromes.Current neurology and neuroscience reports · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Juliette PiardCentre de Génétique Humaine, Université de Franche-Comté, CHU, Besançon, France.ORCID 0000-0001-5244-5325
Matthieu BéreauUnité de recherche en neurosciences intégratives et cognitives EA481, Université de Franche-Comté, Besançon, France.ORCID 0000-0003-0769-0289
Wenshu XiangWeiDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0003-2456-4057
Thomas WirthDépartement de Neurologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0002-4427-5765
Daniel AmsallemService de Neuropédiatrie, CHU, Besançon, France.
Lauren BuissonService de Neuropédiatrie, CHU, Besançon, France.
Philippe RichardService de Neurologie, CHU, Besançon, France.
Nana LiuDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-0135-3575
Yuchen XuDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-1448-2800
Scott J MyersDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-6689-3978
Stephen F TraynelisDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-3750-9615
Jameleddine ChellyInstitut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
Mathieu AnheimDépartement de Neurologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0001-8121-0605
Martine RaynaudCHRU de Tours, Service de Génétique, Tours, France.ORCID 0000-0002-6888-6480
Lionel Van MaldergemCentre de Génétique Humaine, Université de Franche-Comté, CHU, Besançon, France.ORCID 0000-0001-8880-5214
Hongjie YuanDepartment of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-8127-7145
Centre Hospitalier Universitaire de Besançon · FREmory University · USInstitut de génétique et de biologie moléculaire et cellulaire · FRCentral South University · CNHôpitaux Universitaires de Strasbourg · FRUniversité de franche-comté · FRUniversité de Tours · FR

Funding

Glutamate receptors and human neurological diseaseR35NS111619 · NINDS · EMORY UNIVERSITY · PI Stephen F Traynelis · 2019 to 2026
$6.6M
Control of Glutamate Receptor FunctionR01NS036654 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 1998 to 2018
$3.7M
Mechanism of Action of Novel Subunit-Selective NMDA Receptor ModulatorsR01NS065371 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2009 to 2018
$3.4M
NMDAR Mutations & Neurodevelopmental Disorder: from Mechanism to Targeted TherapyR01HD082373 · NICHD · EMORY UNIVERSITY · PI YUAN, HONGJIE · 2015 to 2025
$3.3M
Functional effects of ion channel mutations found via exome sequencingR24NS092989 · NINDS · EMORY UNIVERSITY · PI TRAYNELIS, STEPHEN F · 2016 to 2019
$1.1M
NICHD NIH HHS R01 HD082373NINDS NIH HHS R01 NS036654NINDS NIH HHS R01 NS065371NINDS NIH HHS R24 NS092989NINDS NIH HHS R35 NS111619
6 · The paper itself

Abstract

backgroundHemizygous mutations in GRIA3 encoding the GluA3 subunit of the amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor are known to be associated with neurodevelopmental disorders, including intellectual disability, hypotonia, an autism spectrum disorder, sleep disturbances, and epilepsy in males.

objectiveTo describe a new and consistent phenotype in 4 affected male patients associated with an undescribed deleterious variant in GRIA3.

methodsWe evaluated a large French family in which segregate a singular phenotype according to an apparent X-linked mode of inheritance. Molecular analyses using next generation sequencing and in vitro functional studies using 2-electrode voltage clamp recordings on Xenopus laevis oocytes and a β-lactamase reporter assay in transfected human embryonic kidney (HEK293) cells were performed.

resultsIn addition to mild intellectual disability and dysarthria, affected patients presented a tightly consistent early-onset movement disorder combining an exaggerated startle reflex with generalized chorea and multifocal myoclonus. The unreported GRIA3 missense variant c.2477G > A; p.(Gly826Asp) affecting the fourth transmembrane domain of the protein was identified in index patients and their unaffected mothers. Functional studies revealed that variant receptors show decreased current response evoked by agonist (ie, kainic acid and glutamate) and reduced expression on the cell surface in favor of pathogenicity by a loss-of-function mechanism.

conclusionsTaken together, our results suggest that apart from known GRIA3-related disorders, an undescribed mutation-specific singular movement disorder does exist. We thus advocate considering GRIA3 mutations in the differential diagnosis of hyperekplexia and generalized chorea with myoclonus. © 2020 International Parkinson and Movement Disorder Society.

Indexed as

Autism Spectrum DisorderChoreaMyoclonusHEK293 CellsHumansMaleReflex, StartleAMPA receptorchoreaglutamate receptorGRIA3myoclonus

Identifiers

PMID32369665
PMCPMC9190290
OpenAlexW3021054226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.